NCT00282230View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

PHASE2TerminatedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

October 31, 2005

Conditions
Kidney Transplantation
Interventions
DRUG

FK778

Trial Locations (23)

10021

New York

10029

New York

17104

Harrisburg

19107

Philadelphia

20010

Washington D.C.

27710

Durham

32216

Jacksonville

33136

Miami

35294

Birmingham

38163

Memphis

45267

Cincinnati

46202

Indianapolis

53226

Milwaukee

53792

Madison

60637

Chicago

67214

Wichita

70121

New Orleans

80262

Denver

Detroit

84132

Salt Lake City

89003

New Brunswick

90057

Los Angeles

92123

San Diego

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY